Artificial intelligence in Healthcare Global Market – Forecast To 2027

Publishing Date : November, 2020
Report Code : HCIT0103
Price:
Single license $4,950
Site license $6,750
Global license $9,000


Note: The report would be dispatched after confirmation of payment

Artificial intelligence (AI) is the collection of computer programs or algorithms or software to make machines smarter and enable them to simulate human intelligence and perform various higher-order value-based tasks like visual perception, translation between languages, decision making and speech recognition. The rapidly evolving vast and complex healthcare industry is slowly deploying AI solutions into its mainstream workflows to increase the productivity of various healthcare services efficiently without burdening the healthcare personnel, to streamline and optimize the various healthcare-associated administrative workflows, to mitigate the physician deficit and burnout issues effectively, to democratize the value-based healthcare services across the globe and to efficiently accelerate the drug discovery and development process.

As estimated by IQ4I Research, the artificial intelligence in healthcare global market is expected to reach $35,323.5 million by 2027 growing at an exponential CAGR from 2020 to 2027 due to the gradual transition from volume to value-based healthcare, the surging need to accelerate and increase the efficiency of drug discovery and clinical trial processes, advancement of precision medicines, escalation of AI as a medical device, increasing prevalence of chronic, communicable diseases and escalating geriatric population and the increasing trend of acquisitions, collaborations, investments in the AI in healthcare market.

Artificial intelligence in healthcare global market is classified based on the application, end-user and geography. Based on the application, the market is segmented into Medical diagnosis, drug discovery, precision medicines, clinical trials, Healthcare Documentation management and others consisting of AI guided robotic surgical procedures and AI-enhanced medical device and pharmaceutical manufacturing processes. The AI-powered Healthcare documentation management solutions segment accounted for the largest revenue in 2020 and is expected to grow at an exponential CAGR from 2020 to 2027. AI-enhanced Drug Discovery solutions segment is the fastest emerging segment, growing at an exponential CAGR from 2020 to 2027.

The artificial intelligence in healthcare global end-users market is grouped into Hospitals and Diagnostic Laboratories, Pharmaceutical companies, Research institutes and other end-users consisting of health insurance companies, medical device and pharmaceutical manufacturers and patients or individuals in the home-care settings. Among these end users, Hospitals and Diagnostic Laboratories segment accounted for the largest revenue in 2020 and is expected to grow at an exponential CAGR during the forecasted period. Pharmaceutical companies segment is the fastest-growing segment, growing at an exponential CAGR from 2020 to 2027.

The artificial intelligence in healthcare global market by geography is segmented into North America, Europe, Asia-Pacific and the Rest of the world (RoW). North American region dominated the global artificial intelligence in healthcare market in 2020 and is expected to grow at an exponential CAGR from 2020 to 2027. The Asia-Pacific region is the fastest-growing region, growing at an exponential CAGR from 2020 to 2027.

The artificial intelligence in healthcare market is consolidated with the top five players occupying majority of the market share and the remaining minority share of the market being occupied by other players. The top players in artificial intelligence in healthcare global market are International Business Machines (IBM) Corporation (IBM Watson) (U.S.), General Electric Company (U.S.), Microsoft Corporation (U.S.), Alphabet Inc. (U.S.), Nuance Communications Inc. (U.S.), Intel Corporation (U.S.), Medtronic PLC (Ireland), Nvidia Corporation (U.S.), Welltok Inc. (U.S.), Koninklijke Philips N.V. (The Netherlands), Babylon Health (U.K.), Recursion Pharmaceuticals Inc. (U.S.), Zebra Medical Vision, Inc. (Israel), Insilico Medicine Inc. (Hong Kong), Sensely Inc. (U.S.), Atomwise, Inc. (U.S.), Beijing Infervision Technology Co., Ltd (China) and others.

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

  • North America
  • U.S.
  • Europe
  • U.K.
  • Asia-Pacific 
  • China
  • Rest of the World (RoW)
  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKEAWAYS
    • 2.2     SCOPE OF THE REPORT
    • 2.3     REPORT DESCRIPTION
    • 2.4     MARKETS COVERED
    • 2.5     STAKEHOLDERS
    • 2.6     RESEARCH METHODOLOGY
      • 2.6.1     MARKET SIZE ESTIMATION
      • 2.6.2     MARKET BREAKDOWN AND DATA TRIANGULATION
      • 2.6.3     SECONDARY SOURCES
      • 2.6.4     PRIMARY SOURCES
      • 2.6.5     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.6.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.6.7     ASSUMPTIONS
  • 3     MARKET ANALYSIS
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
      • 3.3.1     DRIVERS AND OPPORTUNITIES
        • 3.3.1.1     AIABETTING THE TRANSITION FROM VOLUME BASED TO VALUE BASED HEALTHCARE
        • 3.3.1.2     ACCELERATION AND INCREASING EFFICIENCY OF DRUG DISCOVERY AND CLINICAL TRIALS
        • 3.3.1.3     ESCALATION OF ARTIFICIAL INTELLIGENCE AS A MEDICAL DEVICE
        • 3.3.1.4     ADVANCEMENT OF PRECISION MEDICINES
        • 3.3.1.5     ACQUISITIONS, INVESTMENTS AND COLLABORATIONS TO OPEN AN ARRAY OF OPPORTUNITIES FOR THE MARKET TO FLOURISH
        • 3.3.1.6     INCREASING PREVALENCE OF CHRONIC, COMMUNICABLE DISEASES AND ESCALATING GERIATRIC POPULATION
      • 3.3.2     RESTRAINTS AND THREATS
        • 3.3.2.1     DATA PRIVACY ISSUES
        • 3.3.2.2     RELIABILITY ISSUES AND BLACK BOX REASONING CHALLENGES
        • 3.3.2.3     ETHICAL ISSUES AND INCREASING CONCERNS OVER HUMAN WORKFORCE REPLACEMENT
        • 3.3.2.4     REQUIREMENT OF HUGE INVESTMENT FOR THE DEPLOYMENT OF AI SOLUTIONS
        • 3.3.2.5     LACK OF INTEROPERABILITY BETWEEN AI VENDORS
    • 3.4     REGULATORY AFFAIRS
      • 3.4.1     INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
        • 3.4.1.1     ISO 9001: 2015 QUALITY MANAGEMENT SYSTEM
        • 3.4.1.2     ISO 13485 MEDICAL DEVICES
        • 3.4.1.3     ISO 14971: RISK MANAGEMENT OF MEDICAL DEVICES
        • 3.4.1.4     IEC 60601-1 MEDICAL ELECTRICAL EQUIPMENT STANDARD
        • 3.4.1.5     IEC 60601-1-11 HOME CARE SAFETY
      • 3.4.2     ASTM INTERNATIONAL STANDARDS
      • 3.4.3     U.S.
      • 3.4.4     CANADA
      • 3.4.5     EUROPE
      • 3.4.6     JAPAN
      • 3.4.7     CHINA
      • 3.4.8     INDIA
    • 3.5     PORTER'S FIVE FORCE ANALYSIS
      • 3.5.1     THREAT OF NEW ENTRANTS
      • 3.5.2     THREAT OF SUBSTITUTES
      • 3.5.3     BARGAINING POWER OF SUPPLIERS
      • 3.5.4     BARGAINING POWER OF BUYERS
      • 3.5.5     COMPETITIVE RIVALRY
    • 3.6     CLINICAL TRIALS
    • 3.7     FUNDING SCENARIO
    • 3.8     REGIONAL ANALYSIS OF AI START-UPS
    • 3.9     ARTIFICIAL INTELLIGENCE IN HEALTHCARE FDA APPROVAL ANALYSIS
    • 3.10     AI LEVERAGING KEY DEAL ANALYSIS
    • 3.11     AI ENHANCED HEALTHCARE PRODUCTS PIPELINE
    • 3.12     PATENT TRENDS
    • 3.13     MARKET SHARE ANALYSIS BY MAJOR PLAYERS
      • 3.13.1     ARTIFICIAL INTELLIGENCE IN HEALTHCARE GLOBAL MARKET SHARE ANALYSIS
    • 3.14     ARTIFICIAL INTELLIGENCE IN HEALTHCARE COMPANY COMPARISON TABLE BY APPLICATION, SUB-CATEGORY, PRODUCT/TECHNOLOGY AND END-USER
  • 4     ARTIFICIAL INTELLIGENCE IN HEALTHCARE GLOBAL MARKET, BY APPLICATION
    • 4.1     INTRODUCTION
    • 4.2     MEDICAL DIAGNOSIS
    • 4.3     DRUG DISCOVERY
    • 4.4     CLINICAL TRIALS
    • 4.5     PRECISION MEDICINE
    • 4.6     HEALTHCARE DOCUMENTATION MANAGEMENT
    • 4.7     OTHER APPLICATION
  • 5     ARTIFICIAL INTELLIGENCE IN HEALTHCARE GLOBAL MARKET, BY END-USER
    • 5.1     INTRODUCTION
    • 5.2     HOSPITALS AND DIAGNOSTIC LABORATORIES
    • 5.3     PHARMACEUTICAL COMPANIES
    • 5.4     RESEARCH INSTITUTES
    • 5.5     OTHER END-USERS
  • 6     REGIONAL ANALYSIS
    • 6.1     INTRODUCTION
    • 6.2     NORTH AMERICA
      • 6.2.1     U.S.
    • 6.3     EUROPE
      • 6.3.1     U.K.
    • 6.4     APAC
      • 6.4.1     CHINA
    • 6.5     REST OF WORLD (ROW)
  • 7     COMPETITIVE LANDSCAPE
    • 7.1     INTRODUCTION
    • 7.2     PARTNERSHIPS
    • 7.3     PRODUCT LAUNCH
    • 7.4     COLLABORATION
    • 7.5     UP-GRADATION
    • 7.6     ADOPTION
    • 7.7     PRODUCT APPROVAL
    • 7.8     ACQUISITION
    • 7.9     OTHERS
  • 8     MAJOR COMPANIES
    • 8.1     ALPHABET INC. (GOOGLE DEEPMIND, VERILY LIFESCIENCES)
      • 8.1.1     OVERVIEW
      • 8.1.2     FINANCIALS
      • 8.1.3     PRODUCT PORTFOLIO
      • 8.1.4     KEY DEVELOPMENTS
      • 8.1.5     BUSINESS STRATEGY
      • 8.1.6     SWOT ANALYSIS
    • 8.2     GENERAL ELECTRIC COMPANY
      • 8.2.1     OVERVIEW
      • 8.2.2     FINANCIALS
      • 8.2.3     PRODUCT PORTFOLIO
      • 8.2.4     KEY DEVELOPMENTS
      • 8.2.5     BUSINESS STRATEGY
      • 8.2.6     SWOT ANALYSIS
    • 8.3     INTEL CORPORATION
      • 8.3.1     OVERVIEW
      • 8.3.2     FINANCIALS
      • 8.3.3     PRODUCT PORTFOLIO
      • 8.3.4     KEY DEVELOPMENTS
      • 8.3.5     BUSINESS STRATEGY
      • 8.3.6     SWOT ANALYSIS
    • 8.4     INTERNATIONAL BUSINESS MACHINES CORPORATION (IBM WATSON)
      • 8.4.1     OVERVIEW
      • 8.4.2     FINANCIALS
      • 8.4.3     PRODUCT PORTFOLIO
      • 8.4.4     KEY DEVELOPMENTS
      • 8.4.5     BUSINESS STRATEGY
      • 8.4.6     SWOT ANALYSIS
    • 8.5     KONINKLIJKE PHILIPS N.V.
      • 8.5.1     OVERVIEW
      • 8.5.2     FINANCIALS
      • 8.5.3     PRODUCT PORTFOLIO
      • 8.5.4     KEY DEVELOPMENTS
      • 8.5.5     BUSINESS STRATEGY
      • 8.5.6     SWOT ANALYSIS
    • 8.6     MEDTRONIC PUBLIC LIMITED COMPANY
      • 8.6.1     OVERVIEW
      • 8.6.2     FINANCIALS
      • 8.6.3     PRODUCT PORTFOLIO
      • 8.6.4     KEY DEVELOPMENTS
      • 8.6.5     BUSINESS STRATEGY
      • 8.6.6     SWOT ANALYSIS
    • 8.7     MICROSOFT CORPORATION
      • 8.7.1     OVERVIEW
      • 8.7.2     FINANCIALS
      • 8.7.3     PRODUCT PORTFOLIO
      • 8.7.4     KEY DEVELOPMENTS
      • 8.7.5     BUSINESS STRATEGY
      • 8.7.6     SWOT ANALYSIS
    • 8.8     NUANCE COMMUNICATIONS INC.
      • 8.8.1     OVERVIEW
      • 8.8.2     FINANCIALS
      • 8.8.3     PRODUCT PORTFOLIO
      • 8.8.4     KEY DEVELOPMENTS
      • 8.8.5     BUSINESS STRATEGY
      • 8.8.6     SWOT ANALYSIS
    • 8.9     NVIDIA CORPORATION
      • 8.9.1     OVERVIEW
      • 8.9.2     FINANCIALS
      • 8.9.3     PRODUCT PORTFOLIO
      • 8.9.4     KEY DEVELOPMENTS
      • 8.9.5     BUSINESS STRATEGY
      • 8.9.6     SWOT ANALYSIS
    • 8.10     WELLTOK INC.
      • 8.10.1     OVERVIEW
      • 8.10.2     FINANCIALS
      • 8.10.3     PRODUCT PORTFOLIO
      • 8.10.4     KEY DEVELOPMENTS
      • 8.10.5     BUSINESS STRATEGY
      • 8.10.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     ARTIFICIAL INTELLIGENCE IN HEALTHCARE GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 2     HEALTHCARE AI START-UPS, BY APPLICATION
      • TABLE 3     FDA APPROVALS (2019-2020)
      • TABLE 4     AI ENHANCED HEALTHCARE PRODUCTS PIPELINE
      • TABLE 5     ARTIFICIAL INTELLIGENCE IN HEALTHCARE GLOBAL MARKET REVENUE, BY APPLICATION, (2019-2027) ($MN)
      • TABLE 6     MEDICAL DIAGNOSIS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 7     DRUG DISCOVERY GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 8     CLINICAL TRIALS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 9     PRECISION MEDICINE GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 10     HEALTHCARE DOCUMENTATION MANAGEMENT GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 11     OTHER APPLICATIONS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 12     ARTIFICIAL INTELLIGENCE IN HEALTHCARE GLOBAL MARKET REVENUE, BY END-USER, (2019-2027) ($MN)
      • TABLE 13     HOSPITALS AND DIAGNOSTIC LABORATORIES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 14     PHARMACEUTICAL COMPANIES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 15     RESEARCH INSTITUTES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 16     OTHER END-USERS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 17     ARTIFICIAL INTELLIGENCE IN HEALTHCARE GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 18     NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET REVENUE, BY APPLICATION, (2019-2027) ($MN)
      • TABLE 19     NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET REVENUE, BY END-USER, (2019-2027) ($MN)
      • TABLE 20     EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET REVENUE, BY APPLICATION, (2019-2027) ($MN)
      • TABLE 21     EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET REVENUE, BY END-USER, (2019-2027) ($MN)
      • TABLE 22     APAC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET REVENUE, BY APPLICATION, (2019-2027) ($MN)
      • TABLE 23     APAC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET REVENUE, BY END-USER, (2019-2027) ($MN)
      • TABLE 24     ROW ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET REVENUE, BY APPLICATION, (2019-2027) ($MN)
      • TABLE 25     ROW ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET REVENUE, BY END-USER, (2019-2027) ($MN)
      • TABLE 26     PARTNERSHIPS (2019-2020)
      • TABLE 27     PRODUCT LAUNCH (2019-2020)
      • TABLE 28     COLLABORATION (2019-2020)
      • TABLE 29     UP-GRADATION (2019-2020)
      • TABLE 30     ADOPTION (2019-2020)
      • TABLE 31     PRODUCT APPROVAL (2019-2020)
      • TABLE 32     ACQUISITION (2019-2020)
      • TABLE 33     OTHERS (2019-2020)
      • TABLE 34     ALPHABET INC.: TOTAL REVENUE AND R&D EXPENSES (2018-2020) ($MN)
      • TABLE 35     ALPHABET INC.: TOTAL REVENUE, BY SEGMENTS (2018-2020) ($MN)
      • TABLE 36     ALPHABET INC.: GOOGLE SEGMENT REVENUE, (2018-2020) ($MN)
      • TABLE 37     ALPHABET INC.: TOTAL REVENUE, BY GEOGRAPHY (2018-2020) ($MN)
      • TABLE 38     GENERAL ELECTRIC: TOTAL REVENUE AND R&D EXPENSES, (2018-2020) ($MN)
      • TABLE 39     GENERAL ELECTRIC: TOTAL REVENUE, BY PRODUCT SEGMENTS, (2018-2020) ($MN)
      • TABLE 40     GENERAL ELECTRIC: INDUSTRIAL SEGMENT REVENUE (2018-2020) ($MN)
      • TABLE 41     GENERAL ELECTRIC: HEALTHCARE SEGMENT REVENUE, (2018-2020) ($MN)
      • TABLE 42     GENERAL ELECTRIC: TOTAL REVENUE, BY GEOGRAPHY, (2018-2020) ($MN)
      • TABLE 43     INTEL CORPORATION: TOTAL SALES AND R&D EXPENSES, (2018-2020) ($MN)
      • TABLE 44     INTEL CORPORATION: TOTAL SALES, BY SEGMENTS, (2018-2020) ($MN)
      • TABLE 45     INTEL CORPORATION: INTERNET OF THINGS SEGMENT REVENUE, (2018-2020) ($MN)
      • TABLE 46     INTEL CORPORATION: TOTAL SALES, BY GEOGRAPHY, (2018-2020) ($MN)
      • TABLE 47     INTERNATIONAL BUSINESS MACHINES CORP.: TOTAL REVENUE AND R&D EXPENSES, (2018-2020) ($MN)
      • TABLE 48     INTERNATIONAL BUSINESS MACHINES CORP.: TOTAL REVENUE, BY SEGMENTS, (2018-2020) ($MN)
      • TABLE 49     INTERNATIONAL BUSINESS MACHINES CORP.: CLOUD & COGNITIVE SOFTWARE SEGMENT REVENUE (2018-2020) ($MN)
      • TABLE 50     INTERNATIONAL BUSINESS MACHINES CORP.: TOTAL REVENUE, BY GEOGRAPHY, (2018-2020) ($MN)
      • TABLE 51     PHILIPS : TOTAL REVENUE AND R&D EXPENSES, (2018-2020) ($MN)
      • TABLE 52     PHILIPS: TOTAL REVENUE BY PRODUCT SEGMENTS, (2018-2020) ($MN)
      • TABLE 53     PHILIPS: TOTAL REVENUE BY GEOGRAPHY, (2018-2020) ($MN)
      • TABLE 54     MEDTRONIC PLC.: TOTAL SALES AND R&D EXPENSES, (2018-2020) ($MN)
      • TABLE 55     MEDTRONIC PLC.: TOTAL SALES, BY SEGMENTS, (2018 -2020) ($MN)
      • TABLE 56     MEDTRONIC PLC.: MINIMALLY INVASIVE THERAPIES GROUP SEGMENT REVENUE, (2018 -2020) ($MN)
      • TABLE 57     MEDTRONIC PLC.: RESTORATIVE THERAPIES GROUP, REVENUE (2018 -2020) ($MN)
      • TABLE 58     MEDTRONIC PLC.: TOTAL SALES, BY GEOGRAPHY, (2018 - 2020) ($MN)
      • TABLE 59     MICROSOFT CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2019-2021) ($MN)
      • TABLE 60     MICROSOFT CORPORATION: TOTAL REVENUE, BY SEGMENT, (2019-2021) ($MN)
      • TABLE 61     MICROSOFT CORPORATION: PRODUCT AND SERVICE OFFERINGS SUB-SEGMENT REVENUE (2019 -2021) ($MN)
      • TABLE 62     MICROSOFT CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2019 -2021) ($MN)
      • TABLE 63     NUANCE COMMUNICATIONS INC.: TOTAL REVENUE AND R&D EXPENSES, (2018 -2020) ($MN)
      • TABLE 64     NUANCE COMMUNICATIONS INC.: TOTAL REVENUE, BY SEGMENTS (2018-2020) ($MN)
      • TABLE 65     NUANCE: TOTAL REVENUE, BY GEOGRAPHY, (2018-2020) ($MN)
      • TABLE 66     NVIDIA CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2018-2020) ($MN)
      • TABLE 67     NVIDIA CORPORATION: TOTAL REVENUE, BY SPECIALIZED MARKET SEGMENTS, (2018-2020) ($MN)
      • TABLE 68     NVIDIA CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2018-2020) ($MN)

      LIST OF FIGURES

      • FIGURE 1     ARTIFICIAL INTELLIGENCE IN HEALTHCARE GLOBAL MARKET REVENUE, BY REGION (2019-2027) ($MN)
      • FIGURE 2     RESEARCH METHODOLOGY: ARTIFICIAL INTELLIGENCE IN HEALTHCARE GLOBAL MARKET
      • FIGURE 3     ARTIFICIAL INTELLIGENCE IN HEALTHCARE GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     ARTIFICIAL INTELLIGENCE IN HEALTHCARE GLOBAL MARKET: FORECASTING MODEL
      • FIGURE 5     ARTIFICIAL INTELLIGENCE IN HEALTHCARE GLOBAL MARKET: MARKET BREAKDOWN AND DATA TRIANGULATION
      • FIGURE 6     ARTIFICIAL INTELLIGENCE IN HEALTHCARE GLOBAL MARKET SEGMENTATION
      • FIGURE 7     MARKET DYNAMICS
      • FIGURE 8     ARTIFICIAL INTELLIGENCE IN HEALTHCARE GLOBAL MARKET: PORTER'S ANALYSIS
      • FIGURE 9     CLINICAL TRIALS (2018 - 2020)
      • FIGURE 10     FUNDING SCENARIO, (2019 - 2020)
      • FIGURE 11     REGIONAL ANALYSIS OF AI START-UPS, (2010 - 2020)
      • FIGURE 12     KEY DEAL ANALYSIS, (2019 - 2020)
      • FIGURE 13     PATENT TRENDS (2016 - 2020)
      • FIGURE 14     ARTIFICIAL INTELLIGENCE IN HEALTHCARE GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
      • FIGURE 15     ARTIFICIAL INTELLIGENCE IN HEALTHCARE GLOBAL MARKET SHARE, BY APPLICATION (2020 V/S 2027) (%)
      • FIGURE 16     DRUG DISCOVERY GLOBAL MARKET SHARE, BY REGION (2020 V/S 2027) (%)
      • FIGURE 17     CLINICAL TRIALS GLOBAL MARKET SHARE, BY REGION (2020 V/S 2027) (%)
      • FIGURE 18     ARTIFICIAL INTELLIGENCE IN HEALTHCARE GLOBAL MARKET SHARE, BY END-USER (2020 V/S 2027) (%)
      • FIGURE 19     ARTIFICIAL INTELLIGENCE IN HEALTHCARE GLOBAL MARKET REVENUE, BY REGION (2019-2027) ($MN), CAGR (%)
      • FIGURE 20     NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SHARE, BY APPLICATION (2020) (%), CAGR (%)
      • FIGURE 21     NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SHARE, BY END-USER (2020 V/S 2027) (%)
      • FIGURE 22     EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SHARE, BY APPLICATION (2020) (%), CAGR (%)
      • FIGURE 23     EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SHARE, BY END-USER (2020 V/S 2027) (%)
      • FIGURE 24     APAC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SHARE, BY APPLICATION (2020) (%), CAGR (%)
      • FIGURE 25     APAC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SHARE, BY END-USER (2020 V/S 2027) (%)
      • FIGURE 26     ROW ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SHARE, BY APPLICATION (2020) (%), CAGR (%)
      • FIGURE 27     ROW ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SHARE, BY END-USER (2020 V/S 2027) (%)
      • FIGURE 28     KEY GROWTH STRATEGIES, (2019-2020)
      • FIGURE 29     SWOT: ALPHABET INC.
      • FIGURE 30     SWOT: GENERAL ELECTRIC
      • FIGURE 31     SWOT: INTEL CORPORATION
      • FIGURE 32     SWOT: INTERNATIONAL BUSINESS MACHINES CORP.
      • FIGURE 33     SWOT: PHILIPS
      • FIGURE 34     SWOT: MEDTRONIC PLC.
      • FIGURE 35     SWOT: MICROSOFT CORPORATION
      • FIGURE 36     SWOT: NUANCE COMMUNICATIONS INC.
      • FIGURE 37     SWOT: NVIDIA CORPORATION.
      • FIGURE 38     SWOT: WELLTOK INC.

      LIST OF COMPANIES MENTIONED IN THE REPORT

      • 1     3BIGS
      • 2     A2A Pharmaceuticals
      • 3     Abalone Bio
      • 4     AbCellera
      • 5     Ablacon Inc.
      • 6     Accutar Biotech
      • 7     Acurastem
      • 8     Ada Health
      • 9     Adagene
      • 10     Aetion
      • 11     AI Therapeutics
      • 12     AiCure LLC
      • 13     Aidoc
      • 14     Aiforia
      • 15     Aiva Health
      • 16     Allstripes (RDMD)
      • 17     Alphabet Inc.
      • 18     Alphanosos
      • 19     Amplion
      • 20     Antidote.me
      • 21     Antiverse
      • 22     Apixio
      • 23     Aqemia
      • 24     Arbor Biotechnologies
      • 25     Arctoris
      • 26     Ardigen
      • 27     Ares Genetics
      • 28     Arterys Inc.
      • 29     ArtiQ
      • 30     Athelas
      • 31     Atomwise, Inc.
      • 32     Aural Analytics
      • 33     Auransa
      • 34     Autism & beyond
      • 35     Babylon Health
      • 36     BeaconCure
      • 37     Behold.ai Technologies Limited
      • 38     Beijing Infervision Co., Ltd
      • 39     BenchSci
      • 40     BenevolentAI
      • 41     Berkeley Lights
      • 42     Beyond Verbal
      • 43     BigHat Biosciences
      • 44     Bio Conscious Technologies
      • 45     BioAge Labs
      • 46     Biofourmis
      • 47     Biorelate
      • 48     BioSymetrics
      • 49     Biotrillion
      • 50     Biotx.ai
      • 51     BioXcel Therapeutics
      • 52     BlackThorn Therapeutics
      • 53     Bodyport
      • 54     Bot M.D.
      • 55     Braid Health
      • 56     BrainQ
      • 57     BullFrog AI
      • 58     Buoy Health
      • 59     Cambridge Cancer Genomics
      • 60     Caption Health
      • 61     CardiodiagnosticsInc. Inc.
      • 62     Cardiologs
      • 63     CarePredict
      • 64     CareVoice
      • 65     CaroCure
      • 66     Castor
      • 67     Causaly
      • 68     Cellarity
      • 69     CellmatiQ
      • 70     Celsium
      • 71     Celsius Therapeutics
      • 72     ChemPass
      • 73     Clarify Health
      • 74     Clearstep
      • 75     Cloud Pharmaceuticals
      • 76     CloudMedx
      • 77     Clover Therapeutics
      • 78     Collaborations Pharma
      • 79     Color
      • 80     Concerto HealthAI
      • 81     ContinUse Biometrics
      • 82     Coral Genomics
      • 83     Corti ApS
      • 84     Cover2Protect
      • 85     Curai
      • 86     Curemetrix
      • 87     Current Health
      • 88     Cyclica
      • 89     Cyrcadia Health
      • 90     CytoReason
      • 91     Data2Discovery
      • 92     Data4Cure
      • 93     Datavant
      • 94     Deep 6 AI
      • 95     Deep Genomics Inc.
      • 96     Deep Intelligent Pharma
      • 97     Deep Lens
      • 98     DeePathology.ai
      • 99     DeepMatter
      • 100     DeepTrait
      • 101     Delta 4
      • 102     Denovicon Therapeutics
      • 103     Desktop Genetics
      • 104     Dexstr
      • 105     diagnostics.ai
      • 106     Doc.ai
      • 107     DocSynk
      • 108     Dyno Therapeutics
      • 109     Eigengene
      • 110     Eko
      • 111     Elucidata Corporation
      • 112     Emedgene
      • 113     Emerald Cloud Lab
      • 114     EmpiricLogic
      • 115     Empirico
      • 116     Engine Biosciences
      • 117     Enlitic Inc.
      • 118     EntheogeniX Biosciences
      • 119     Envisagenics
      • 120     Erasca
      • 121     Euretos
      • 122     Evid Science
      • 123     Evidation Health
      • 124     Exploris AG
      • 125     Exscientia
      • 126     EyeControl
      • 127     Ezra
      • 128     FDNA
      • 129     Ferrum
      • 130     Fetch Biosciences
      • 131     FitGenie
      • 132     Fountain Therapeutics
      • 133     Freenome
      • 134     Frontier Medicines
      • 135     Gatehouse Bio
      • 136     General Electric Company
      • 137     General Vision, Inc.
      • 138     Genesis Therapeutics
      • 139     Genialis
      • 140     Geras Solutions
      • 141     Gero
      • 142     Gleamer
      • 143     Globavir
      • 144     Glympse Bio
      • 145     Gordian Biotechnology
      • 146     Gritstone Oncology
      • 147     GT Apeiron Therapeutics
      • 148     GTN
      • 149     HACARUS
      • 150     Harrison.ai
      • 151     Haut.AI
      • 152     Haystack Sciences
      • 153     Health[at]Scale
      • 154     HealthifyMe
      • 155     Healthy.io
      • 156     Healx
      • 157     HelixAI
      • 158     HistoIndex
      • 159     HuiMeiHealthcare
      • 160     Huma.ai
      • 161     Huma (Medopad)
      • 162     Ibex Medical Analytics
      • 163     IBM Corporation (IBM Watson)
      • 164     iCarbonX
      • 165     Idx
      • 166     Iktos
      • 167     Imagia
      • 168     Inato
      • 169     Infermedica
      • 170     Innoplexus
      • 171     Insightin Health
      • 172     InsightRX
      • 173     Insiliance
      • 174     Insilico Medicine Inc.
      • 175     Insitro
      • 176     Intel Corporation
      • 177     Intellegens
      • 178     Intelligencia
      • 179     InveniAI
      • 180     inveox
      • 181     InVivo AI
      • 182     Iris.ai
      • 183     iThermo (KroniKare.ai)
      • 184     Jvion
      • 185     K Health
      • 186     Kaia Health
      • 187     Keen Eye Technologies
      • 188     KenSci
      • 189     Koninklijke Philips N.V.(Royal Philips)
      • 190     Kyndi
      • 191     LabGenius
      • 192     LabTwin GmbH
      • 193     LabVoice
      • 194     Lantern Pharma
      • 195     Lark
      • 196     Leben Care
      • 197     LeanTaas
      • 198     Life Whisperer
      • 199     Lifebit
      • 200     Lodo Therapeutics
      • 201     Lumiata
      • 202     Lunit
      • 203     LynxCare
      • 204     MAbSilico
      • 205     Massive Bio
      • 206     Maverick Medical AI
      • 207     MaxQ AI
      • 208     Medable
      • 209     Medignition
      • 210     Mediktor
      • 211     MediRita
      • 212     Medtronic PLC
      • 213     MedWhat
      • 214     Mendel.ai
      • 215     Menten Biotechnology Labs
      • 216     Meta
      • 217     Micar Innovation
      • 218     Microsoft Corporation
      • 219     Molecular Health GmbH
      • 220     Molecule.one
      • 221     Molomics
      • 222     Mozi
      • 223     mPulse Mobile
      • 224     Myia Labs
      • 225     Nanna Therapeutics
      • 226     NarrativeDx
      • 227     Neon Therapeutics
      • 228     NetraMark
      • 229     NextHealth Technologies Inc.
      • 230     nference
      • 231     Niramai Health Analytix Pvt Ltd
      • 232     Notable
      • 233     Novadiscovery
      • 234     nQ Medical
      • 235     Nuance Communications Inc.
      • 236     Nucleai
      • 237     NuMedii, Inc.
      • 238     Nuritas
      • 239     Nutrino
      • 240     Nvidia Corporation
      • 241     OccamzRazor
      • 242     Olive
      • 243     OM1
      • 244     Omicx
      • 245     Oncocross
      • 246     Oncora Medical Inc.
      • 247     OneThree Biotech
      • 248     OrCam
      • 249     Owkin
      • 250     Oxipit.ai
      • 251     Paige.AI
      • 252     PatchAi
      • 253     PathAI
      • 254     PEACCEL
      • 255     Pearl
      • 256     Pending.ai
      • 257     Pepticom
      • 258     Peptone
      • 259     Percayai
      • 260     Perceiv Research
      • 261     PharmCADD
      • 262     Pharos iBT
      • 263     Phenomic AI
      • 264     Plex Research
      • 265     Polaris Quantum Biotech
      • 266     Potrero Medical
      • 267     Praktice.ai
      • 268     Precisionlife
      • 269     Prognos
      • 270     Proscia
      • 271     ProteinQure
      • 272     Protenus
      • 273     Qrativ
      • 274     Quantib
      • 275     Quantitative Medicine
      • 276     Quartet
      • 277     Qulab
      • 278     Qure.ai
      • 279     Qventus
      • 280     Qynapse
      • 281     Recursion Pharmaceuticals Inc.
      • 282     Relay Therapeutics
      • 283     Remedium
      • 284     RenalytixAI
      • 285     Researchably
      • 286     Resonant Therapeutics
      • 287     Retina AI
      • 288     Reveal Biosciences
      • 289     Reverie Labs
      • 290     ReviveMed
      • 291     Risalto Health
      • 292     Robin Healthcare
      • 293     Scailyte
      • 294     sciNote
      • 295     See-Mode
      • 296     Sema4
      • 297     SEngine Precision Medicine
      • 298     Sensely Inc.
      • 299     Sensyne Health
      • 300     SerenusAI
      • 301     Shivom
      • 302     Sift Healthcare
      • 303     Sight Diagnostics
      • 304     SigTuple Technologies Private Limited
      • 305     Sirenas
      • 306     SkinVision
      • 307     SmartPlate
      • 308     SNAQ
      • 309     Sophia Genetics
      • 310     Sopris Health
      • 311     Sparrho
      • 312     Spring Discovery
      • 313     Spring Health
      • 314     Standigm, Inc.
      • 315     StethoMe
      • 316     StoneWise
      • 317     Strateos
      • 318     Structura Biotechnology
      • 319     StuffThatWorks
      • 320     Suki
      • 321     Sword Health
      • 322     Synsight
      • 323     Synthace
      • 324     Systems Oncology
      • 325     TARA Biosystems
      • 326     Tempus
      • 327     TeselaGen
      • 328     ThoughtSpot
      • 329     TNH Health
      • 330     Transformative AI Ltd.
      • 331     Triage
      • 332     Trials.ai
      • 333     Tricog
      • 334     Turbine.AI
      • 335     twoXAR,Incorporated
      • 336     uBiome
      • 337     Ucare.ai
      • 338     Unlearn.ai
      • 339     Unnatural Products
      • 340     Valo Health LLC (Numerate Inc.)
      • 341     Vara
      • 342     Variational AI
      • 343     Verge Genomics
      • 344     VERISIM Life
      • 345     Vida Health
      • 346     Vine Health
      • 347     Viome
      • 348     Virvio
      • 349     Viz.ai
      • 350     Voxel Cloud
      • 351     Vuno Inc.
      • 352     Vyasa
      • 353     Welltok Inc.
      • 354     WinterLight Labs
      • 355     Wisecube AI
      • 356     Woebot
      • 357     Wysa
      • 358     X-37
      • 359     Xbiome
      • 360     Xcures
      • 361     XtalPi
      • 362     Your.MD Ltd.
      • 363     ZebiAI
      • 364     Zebra Medical Vision Inc.